SightfileU.S. market data from official filings

Companies › MDGL

MADRIGAL PHARMACEUTICALS INC (MDGL)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001157601 · EDGAR filings · Updated 2026-07-20

MADRIGAL PHARMACEUTICALS INC (MDGL) has reported institutional ownership of 103.1%, with 377 institutional managers holding positions valued at $12.4B per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
103.1%
Institutional managers
377
Reported 13F value
$12.4B
Insider activity
329 trans.
−$120.4M net selling
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, MADRIGAL PHARMACEUTICALS INC has 377 institutional holders and institutional ownership of 103.1%.

Insider activity

Insiders reported 329 transactions (54 buys, 231 sells) across 15 reporting insiders, with a net reported value of −$120.4M.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2022-11-03 (recurring since 2022-11-03) — source filing. The authoritative details are those stated in the filing itself.

Related companies

IONIS PHARMACEUTICALS INC (IONS) · GUARDANT HEALTH INC (GH) · ASCENDIS PHARMA A/S SPONSORED (ASND) · JAZZ PHARMACEUTICALS PLC (JAZZ) · ALIGN TECHNOLOGY INC (ALGN) · MEDPACE HLDGS INC (MEDP)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-20.